glp 1 euglycemic dka Life-Saving Awareness: Recognizing and Preventing Ketoacidosis in Patients on SGLT-2 and GLP-1 Therapy Proposed mechanism of euglycemic DKA

The digital-first approach of online platforms appeals particularly to tech-savvy patients who prefer managing their healthcare through mobile apps and online portals

Through partnerships with local manufacturers and producers in the US corn belt, D-allulose is now being distributed and sold as a sweetener in 17 countries

In some embodiments, the otic formulation or composition comprises between about 0.10% to about 20% by weight of the therapeutic agent, or pharmaceutically acceptable prodrug or salt thereof

Heparanase: roles in cell survival, extracellular matrix remodelling and the development of kidney disease

Alimentary Pharmacol Ther